New versions of Tylenol dental professionals need to know about

May 2, 2024
Soon to be in the spotlight and heavily advertised is a new version of acetaminophen—an 80 mg gummy bite designed for kids. Join us in this episode of Medical History Mysteries as we look at what’s Tylenol (and what isn’t).

Every year, 50,000 people are admitted to the hospital with acetaminophen overdose. In fact, acetaminophen the leading cause of liver failure in the US.

Acetaminophen can be a dangerous drug that can easily cause liver toxicity. Since it comes in so many different medications, it can be confusing to know exactly how much acetaminophen you’ve taken in a 24-hour period.

Soon to be in the spotlight and heavily advertised is a new version of acetaminophen—an 80 mg gummy bite designed for kids. There are also many other versions of “Tylenol” on the pharmacy shelves today that aren’t even Tylenol. For this reason and more, it is critical to take a complete and accurate medical history on every patient. You need to know exactly how much (and what kind) of acetaminophen your patients are taking before using any drugs for dental treatment that may add to the daily dosage.

Join us in this episode of Medical History Mysteries as we look at the various types of acetaminophen on the market (and new ones to come) that you need to know about.

Thumbnail background image credit: Helen Slyvinska / iStock / Getty Images Plus

More Medical History Mysteries videos …


The Dental Economics Network brings you the best content from Dental Economics, RDH, DentistryIQ, and Perio-Implant Advisory.

Editor’s note: This article first appeared in Clinical Insights newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe.

About the Author

Pamela Maragliano-Muniz, DMD

Pamela Maragliano-Muniz, DMD, is the chief editor of DentistryIQ and editorial co-director of Through the Loupes. Based in Salem, Massachusetts, Dr. Maragliano-Muniz began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano-Muniz owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].

Related:

Pamela Maragliano-Muniz, DMD, named chief editor of DentistryIQ

About the Author

Tom Viola, RPh, CCP

With more than 30 years’ experience as a board-certified pharmacist, clinical educator, professional speaker, and published author, Tom Viola, RPh, CCP, has earned the reputation as the go-to specialist for making pharmacology practical and useful for dental teams. He is the founder of Pharmacology Declassified and is a member of the faculty of more than 10 dental professional degree programs. Viola has contributed to several professional journals and pharmacology textbooks, and currently serves as a consultant to the American Dental Association’s Council on Scientific Affairs.

Updated February 10, 2022